Christine Duthoit

Title: Christine Duthoit: Innovator in Viral Particle Technology

Introduction

Christine Duthoit is a prominent inventor based in Portet-sur-Garonne, France. She has made significant contributions to the field of biotechnology, particularly in the development of viral particles for RNA transfer. Her innovative work has the potential to impact immune response therapies.

Latest Patents

Christine Duthoit holds a patent for a viral particle designed for the transfer of RNAs, especially into cells involved in immune response. The patent describes a retroviral particle that includes a protein derived from the Gag polyprotein, an envelope protein, and at least two encapsidated non-viral RNAs. Each encapsidated RNA sequence of interest is bound to an encapsidation sequence, which is recognized by a binding domain introduced into the Gag polyprotein or integrase. Notably, at least one of the sequences of interest encodes an epitope or a molecular structure that specifically recognizes an epitope.

Career Highlights

Christine Duthoit is currently associated with Flash Therapeutics, where she continues to advance her research in viral particle technology. Her work is crucial in developing innovative solutions for RNA delivery, which can enhance therapeutic strategies in immunology.

Collaborations

Christine collaborates with talented individuals such as Pascale Bouille and Lucille Lamouroux, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Christine Duthoit's contributions to viral particle technology exemplify her commitment to advancing biotechnology. Her innovative patent and collaborative efforts position her as a key figure in the field, paving the way for future advancements in RNA therapies.